118 related articles for article (PubMed ID: 28163195)
1. Positive selection of type II collagen-reactive CD80
Park C; Kho IS; In Yang J; Kim MJ; Park S; Cha HS; Lee J; Kim TJ
Clin Immunol; 2017 May; 178():64-73. PubMed ID: 28163195
[TBL] [Abstract][Full Text] [Related]
2. Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis.
Carnrot C; Prokopec KE; Råsbo K; Karlsson MC; Kleinau S
Cell Mol Immunol; 2011 Jul; 8(4):296-304. PubMed ID: 21358667
[TBL] [Abstract][Full Text] [Related]
3. Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice.
Zhang HG; Yang P; Xie J; Liu Z; Liu D; Xiu L; Zhou T; Wang Y; Hsu HC; Mountz JD
J Immunol; 2002 Apr; 168(8):4164-72. PubMed ID: 11937577
[TBL] [Abstract][Full Text] [Related]
4. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
[TBL] [Abstract][Full Text] [Related]
5. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.
Chang BY; Huang MM; Francesco M; Chen J; Sokolove J; Magadala P; Robinson WH; Buggy JJ
Arthritis Res Ther; 2011 Jul; 13(4):R115. PubMed ID: 21752263
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
7. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
Bäcklund J; Nandakumar KS; Bockermann R; Mori L; Holmdahl R
J Immunol; 2003 Oct; 171(7):3493-9. PubMed ID: 14500645
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis.
Louis C; Ngo D; D'Silva DB; Hansen J; Phillipson L; Jousset H; Novello P; Segal D; Lawlor KE; Burns CJ; Wicks IP
Arthritis Rheumatol; 2019 Jan; 71(1):50-62. PubMed ID: 30009417
[TBL] [Abstract][Full Text] [Related]
9. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice.
Wang JH; Wu Q; Yang P; Li H; Li J; Mountz JD; Hsu HC
Arthritis Rheum; 2011 Apr; 63(4):1054-64. PubMed ID: 21225691
[TBL] [Abstract][Full Text] [Related]
11. Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis.
Andersson SE; Eneljung T; Tengvall S; Jirholt P; Stern A; Henningsson L; Liang B; Thorarinsdottir K; Kihlberg J; Holmdahl R; Mårtensson IL; Gustafsson K; Gjertsson I
Arthritis Res Ther; 2016 Jun; 18(1):140. PubMed ID: 27301320
[TBL] [Abstract][Full Text] [Related]
12. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
Hutamekalin P; Saito T; Yamaki K; Mizutani N; Brand DD; Waritani T; Terato K; Yoshino S
J Immunol Methods; 2009 Mar; 343(1):49-55. PubMed ID: 19330909
[TBL] [Abstract][Full Text] [Related]
13. Two distinct subpopulations of marginal zone B cells exhibit differential antibody-producing capacities and radioresistance.
Lee S; Ko Y; Lee HW; Oh WJ; Hong HG; Ariyaratne D; Im SJ; Kim TJ
Cell Mol Immunol; 2024 Apr; 21(4):393-408. PubMed ID: 38424169
[TBL] [Abstract][Full Text] [Related]
14. Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.
Huang JC; Vestberg M; Minguela A; Holmdahl R; Ward ES
Int Immunol; 2004 Feb; 16(2):283-93. PubMed ID: 14734614
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
16. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking.
Carter RA; Campbell IK; O'Donnel KL; Wicks IP
Clin Exp Immunol; 2002 Apr; 128(1):44-51. PubMed ID: 11982589
[TBL] [Abstract][Full Text] [Related]
17. Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis.
Chiba A; Tajima R; Tomi C; Miyazaki Y; Yamamura T; Miyake S
Arthritis Rheum; 2012 Jan; 64(1):153-61. PubMed ID: 21904999
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
[TBL] [Abstract][Full Text] [Related]
20. The role of IL-4 in regulation of murine collagen-induced arthritis.
Myers LK; Tang B; Stuart JM; Kang AH
Clin Immunol; 2002 Feb; 102(2):185-91. PubMed ID: 11846461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
